Redefining Corporate Insurance Conduct as Healthcare’s Unpoliced Engine of Inefficiency, Deception, and Wrongdoing

HHTF Staff · 2026-06-06

Hawaiʻi has 12,688 physicians licensed in the state. Only 3,647 are providing active patient care, representing 3,044 full-time-equivalent physicians. Official workforce modeling places the statewide physician shortage at 644 FTEs, rising to 833 FTEs when island geography is taken into account. In a state already short hundreds of physicians, every hour removed from patient care has consequences. ( University of Hawaii )

That is the contradiction at the center of Hawaiʻi healthcare. Public oversight still tends to begin with individual clinical compliance: a physician accused of overbilling, a clinic accused of improper documentation, a personal care aide accused of falsifying time. Those cases matter, but they do not describe the larger machine now shaping access to care. The most consequential pressure on frontline medicine is increasingly upstream, inside the payer and middleman systems that decide whether care is authorized, paid, delayed, narrowed, or denied.

National evidence points in the same direction. A major JAMA review estimated total waste in the United States healthcare system at $760 billion to $935 billion annually, with administrative complexity alone estimated at $265.6 billion. Administrative complexity is not weather. It is made out of contracts, portals, denial codes, prior authorization rules, provider directories, formularies, pharmacy benefit managers, and corporate accounting structures. ( JAMA Network )

Corporate insurance conduct now belongs at the center of healthcare program-integrity enforcement. The relevant question is no longer whether a denial can be defended one claim at a time. The relevant question is whether the operating model makes obstruction profitable at scale. When denial rates are high, appeals are rare, directories are inflated, reimbursement is suppressed, and physician time is consumed by unpaid administrative labor, the system is not merely inefficient. It is structured to extract value from delay.

Oversight that scrutinizes small clinics while treating payer-side extraction as ordinary business practice protects the wrong part of the system. In Hawaiʻi, where physician supply is already inadequate and the population is aging rapidly, this is not an abstract policy problem. It is a direct threat to the primary care foundation of the state.

Inefficiency: The Weaponization of Clinical Time

In a workforce crisis, clinical time is a public resource. It is the raw material out of which diagnosis, continuity, prevention, chronic disease management, family counseling, medication reconciliation, and trust are made. A system that consumes clinical time without producing clinical value is not administrative support. It is capacity destruction.

The prior authorization burden shows the mechanism clearly. The American Medical Association’s 2026 physician survey found that physicians complete an average of 40 prior authorization requests per week and spend about 13 hours per week on prior authorization work. Ninety-five percent of surveyed physicians reported that prior authorization delays care, 79 percent reported that it can lead patients to abandon treatment, 94 percent said it contributes to physician burnout, and 40 percent reported having staff who work exclusively on prior authorization. ( American Medical Association )

Thirteen hours per week is 676 hours per physician per year. That is almost seventeen full forty-hour workweeks. In Hawaiʻi, where the official physician shortage reaches 833 FTEs once geography is accounted for, the loss is not symbolic. It is measurable clinical capacity removed from an already strained care system. ( University of Hawaii )

Hospitals and clinics have been forced to build large non-clinical infrastructures around this payer architecture. The American Hospital Association has estimated that providers spend nearly $39 billion annually on administrative activities related to regulatory compliance, and that the average-sized community hospital devotes 59 full-time-equivalent employees to regulatory compliance work. More than one-quarter of those employees are physicians, nurses, and other health professionals who would otherwise be involved in patient care. ( American Hospital Association )

This is the first extraction. The insurer imposes the rule, but the physician practice pays for the labor required to satisfy it. The payer’s cost-containment apparatus is subsidized by the clinic’s staff time, the physician’s evenings, the patient’s delay, and the erosion of access in communities that already cannot afford to lose more care.

Wrongdoing: Denial as a Business Architecture

The payer market in Hawaiʻi is not a normal competitive marketplace. The American Medical Association’s 2025 analysis of health insurance markets found that 97 percent of commercial metropolitan markets were highly concentrated and ranked Hawaiʻi as the third least competitive commercial health insurance market in the country. Market concentration matters because a dominant payer can impose payment rates, administrative requirements, contract terms, denial processes, and appeal burdens that small independent practices have little realistic power to resist. ( American Medical Association )

Low reimbursement becomes more damaging in Hawaiʻi because the operating costs are not mainland operating costs. Hawaiʻi physician reimbursement analyses have found that geographic Medicare payment adjustments undervalue physician work in the state and do not adequately reflect the local cost of living, staffing, housing, supplies, and practice overhead. Those payment frameworks also matter beyond Medicare because they influence private and Medicare Advantage benchmarks. ( research.hawaii.edu )

Denials compound the pressure. A Kaiser Family Foundation analysis of 2024 HealthCare.gov Marketplace data found that insurers denied 19 percent of in-network claims nationally. Hawaiʻi had the highest average in-network denial rate in that dataset, at 27 percent. Fewer than 1 percent of denied in-network claims were appealed, and insurers upheld 66 percent of appealed denials. ( KFF )

The scope of that dataset matters because accurate enforcement begins with accurate denominators. The KFF analysis concerns post-service HealthCare.gov qualified health plan claims, not every claim in Hawaiʻi and not prior authorization requests. But the pattern is still important: in a major commercial insurance segment, Hawaiʻi sits at the extreme end of a national denial distribution, while appeals remain vanishingly rare. ( KFF )

The business logic is not difficult to see. A payer does not need to win every dispute if the dispute process is too expensive, too slow, or too exhausting for the practice to use. Denial volume becomes financially powerful when the cost of contesting the denial exceeds the value of the claim, especially for small clinics without dedicated legal, billing, or appeal departments.

Federal oversight has already confirmed that inappropriate denials are not hypothetical. The HHS Office of Inspector General found that Medicare Advantage organizations sometimes denied prior authorization requests and payment requests that met Medicare coverage rules. In its sampled cases, OIG found that 13 percent of prior authorization denials and 18 percent of payment denials met Medicare coverage and billing rules. ( HHS Office of Inspector General )

OIG found similar risks in Medicaid managed care. In a review of seven parent companies operating 115 managed care organizations across 37 states, covering 29.8 million people, OIG found that the companies denied one out of eight prior authorization requests in 2019. Twelve plans had denial rates greater than 25 percent, while limited state oversight allowed inappropriate denials to go undetected. ( HHS Office of Inspector General )

This is not a paperwork problem. It is a financial architecture. Low reimbursement, concentrated payer power, high denial rates, rare appeals, and limited external review create a system in which independent practices lose revenue not only through payment rates, but through the cost of fighting for payment after care has already been delivered.

Algorithmic Attrition and the Need for Denial Transparency

The concern becomes more urgent when claims review is automated or semi-automated. A denial system that can process medical claims at industrial speed can also scale errors, omissions, and distorted incentives at industrial speed. Software does not remove accountability from the process. It makes accountability more necessary.

The public record already shows why regulators should not accept proprietary denial systems on trust. Litigation following ProPublica reporting alleged that Cigna used a system known as PxDx to deny claims in bulk as medically unnecessary without meaningful medical-professional review. A federal judge later allowed some claims to proceed past the motion-to-dismiss stage, while making clear that the ruling was not a decision on the merits. ( Courthouse News )

For Hawaiʻi policy, the lesson is larger than any single company. When a payer uses proprietary software, artificial intelligence, rules engines, or batch-processing tools to deny, downgrade, pend, or route claims, regulators should be able to inspect the system. The burden should not fall on an exhausted clinic to prove, one claim at a time, that the machine is functioning improperly.

The audit questions are concrete. Regulators should know how many claims are denied automatically, how many are reviewed by physicians, what specialties those reviewers practice, how long reviews take, how often software recommendations are overridden, how often appeals succeed, and whether denial patterns vary by island, specialty, payer product, race, age, disability, or language access. A system that controls access to medical care should not be allowed to hide its operating logic behind trade secrecy.

Deception: Phantom Networks and the Illusion of Access

A provider directory is not a brochure. It is evidence used to sell coverage, satisfy regulators, reassure employers, and tell patients that care exists. When the directory is false, access is false.

National investigations have exposed the scale of the problem. A U.S. Senate Finance Committee secret-shopper investigation into Medicare Advantage mental health provider directories found that only 18 percent of attempted contacts resulted in an appointment. More than eight in ten listed providers were either inaccurate or not taking new appointments. ( Senate Finance Committee )

OIG reached the same basic conclusion in its review of behavioral health networks. Medicare Advantage plans included, on average, only 16 percent of county behavioral health providers in their networks, while Medicaid managed care plans included 31 percent. OIG also found that, on average, 55 percent of listed Medicare Advantage behavioral health providers and 28 percent of listed Medicaid managed care behavioral health providers had not provided services to any enrolled patients during the year reviewed. Among inactive providers, 72 percent should not have been listed at all. ( HHS Office of Inspector General )

Directory inaccuracies also persist. An AJMC analysis found that 40.3 percent of inaccurate provider directory listings remained inaccurate roughly 540 days later, despite legal requirements for directory verification. The study also noted that provider directory errors can delay or prevent care and can misrepresent whether a plan’s network is adequate. ( AJMC )

Local Hawaiʻi findings make the national problem harder to dismiss as distant. A Hawaiʻi Healthcare Intelligence Platform and Hawaiʻi Healthcare Task Force sampled analysis of 412 provider-directory entries reported that 42 percent failed basic reachability validation and only 31 percent represented verifiably active clinicians accepting new patients. (Retired: the 412-listing sample has no surviving underlying file. The current figure: HMSA's Med-QUEST directory report lists 4,118 primary care providers as accepting new patients, 107 percent more than the 1,994 primary care physicians, APRNs, and PAs practicing statewide.) The analysis characterized the remaining 69 percent as functionally unavailable. ( Hawaiʻi Healthcare Task Force )

This is the second extraction. A health plan collects premiums for access it represents as available, while patients discover the truth only after they begin calling. The spreadsheet says the network exists. The patient’s phone does not.

Deception: The Closed Corporate Loop of the Medical Loss Ratio

The medical loss ratio was designed to force premium dollars toward care. Under the Affordable Care Act, insurers generally must spend 80 to 85 percent of premium revenue on clinical services and quality improvement, with rebates required when they fail to meet the standard. On paper, the rule restrains excessive administrative spending and profit-taking. ( CMS )

Vertical integration changes the meaning of that paper. Large insurers increasingly own or affiliate with pharmacy benefit managers, specialty pharmacies, physician groups, and other healthcare subsidiaries. Brookings researchers have warned that when a Medicare Advantage plan pays a related business, that payment can count as claims spending for medical loss ratio purposes even if part of the payment ultimately becomes profit for the parent company. ( Brookings )

The loophole is not subtle. Once the insurer, PBM, pharmacy, and provider group sit inside the same corporate parent, a dollar can leave the insurance arm as “medical spending” and remain inside the parent enterprise as affiliated revenue. Brookings has explained that transfer pricing can move profit from the regulated insurance plan into a related business, raising the plan’s medical loss ratio without redu